OP2 INNOVATIVE DRUGS Trademark

Trademark Overview

On Tuesday, March 13, 2018, a trademark application was filed for OP2 INNOVATIVE DRUGS with the United States Patent and Trademark Office. The USPTO has given the OP2 INNOVATIVE DRUGS trademark a serial number of 79234141. The federal status of this trademark filing is REGISTERED as of Tuesday, April 21, 2020. This trademark is owned by OP2 DRUGS. The OP2 INNOVATIVE DRUGS trademark is filed in the Chemical Products and Medical Instrument Products categories with the following description:

Chemicals for use in industry and science

Medical apparatus and instruments for treating cardiovascular and neurological disease
op2 innovative drugs

General Information

Serial Number79234141
Word MarkOP2 INNOVATIVE DRUGS
Filing DateTuesday, March 13, 2018
Status700 - REGISTERED
Status DateTuesday, April 21, 2020
Registration Number6035847
Registration DateTuesday, April 21, 2020
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, September 3, 2019

Trademark Statements

Description of MarkThe mark consists of the stylized wording "OP2 INNOVATIVE DRUGS" with the letter "O" being an orange circle, the letter "P" in red, the number "2" in white on a purple circle, above the wording "INNOVATIVE DRUGS" in purple.
Indication of Colors claimedThe color(s) orange, red, purple and white is/are claimed as a feature of the mark.
Goods and ServicesChemicals for use in industry and science
NOT AVAILABLE"DRUGS"
Goods and ServicesMedical apparatus and instruments for treating cardiovascular and neurological disease

Classification Information

International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateFriday, June 15, 2018
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateFriday, June 15, 2018
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameOP2 DRUGS
Party Type30 - Original Registrant
Legal Entity Type34 - NOT AVAILABLE
AddressPESSAC CEDEX F-33604
FR
Party NameOP2 DRUGS
Party Type20 - Owner at Publication
Legal Entity Type34 - NOT AVAILABLE
AddressPESSAC CEDEX F-33604
FR
Party NameOP2 DRUGS
Party Type10 - Original Applicant
Legal Entity Type34 - NOT AVAILABLE
AddressPESSAC CEDEX F-33604
FR

Trademark Events

Event DateEvent Description
Saturday, June 23, 2018ASSIGNED TO EXAMINER
Thursday, June 14, 2018SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, June 15, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, June 19, 2018APPLICATION FILING RECEIPT MAILED
Tuesday, June 26, 2018NON-FINAL ACTION WRITTEN
Wednesday, June 27, 2018NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, July 9, 2018REFUSAL PROCESSED BY MPU
Monday, July 9, 2018NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, July 27, 2018REFUSAL PROCESSED BY IB
Friday, January 4, 2019NEW REPRESENTATIVE AT IB RECEIVED
Tuesday, January 8, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, January 8, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, January 8, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, January 9, 2019PREVIOUS ALLOWANCE COUNT WITHDRAWN
Wednesday, January 9, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, January 21, 2019FINAL REFUSAL WRITTEN
Monday, January 21, 2019FINAL REFUSAL E-MAILED
Monday, January 21, 2019NOTIFICATION OF FINAL REFUSAL EMAILED
Thursday, February 7, 2019NEW REPRESENTATIVE AT IB RECEIVED
Friday, July 19, 2019TEAS REQUEST FOR RECONSIDERATION RECEIVED
Friday, July 19, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, July 20, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, July 30, 2019ASSIGNED TO LIE
Monday, July 22, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 14, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, August 30, 2019NOTIFICATION PROCESSED BY IB
Wednesday, November 20, 2019NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, August 14, 2019NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, August 14, 2019NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Tuesday, September 3, 2019PUBLISHED FOR OPPOSITION
Tuesday, September 3, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Monday, September 30, 2019EXTENSION OF TIME TO OPPOSE RECEIVED
Wednesday, November 20, 2019NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Thursday, March 12, 2020EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Tuesday, April 21, 2020REGISTERED-PRINCIPAL REGISTER
Tuesday, July 21, 2020FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Saturday, September 5, 2020FINAL DISPOSITION NOTICE SENT TO IB
Monday, April 21, 2025COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Saturday, September 26, 2020FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, December 6, 2019NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Thursday, May 7, 2020NEW REPRESENTATIVE AT IB RECEIVED
Wednesday, August 26, 2020FINAL DISPOSITION PROCESSED

Related Keywords

drugs innovative treating cardiovascular neurological disease instruments apparatus industry science medical chemicals